Therapy Areas
Cardio-metabolic & Vascular
Health Security
Influenza & RSV
Solutions for

COVID-19 Vaccine Revenue Forecast 2021-2022

Download Airfinity's COVID-19 Vaccine Market Forecast 2021-2022, covering global demand scenarios, supply & production, and revenue. The report also provides revenue breakdown by vaccine supplier, income band and projected booster demand.
Airfinity background image landing page

We predict Pfizer BioNTech vaccines to earn $10.6 billion in Q3, with Moderna and Astrazeneca to follow with $6.1 and $1 billion. Pfizer and Moderna’s vaccines look set to dominate the market next year due to the vaccines’ high efficacy and rapid scaling of production. Airfinity’s modelling shows Pfizer BioNTech’s sales will increase 77% in 2022, while Moderna’s will increase by 130% next year.

Airfinity background image landing page

For press enquiries, please contact


Sign up to receive the latest insights, product updates and news from Airfinity.

Copyright © Airfinity Limited 2022.
Privacy Policy